Abstract
This study assessed current practice and methods for improvement in the management of families with hereditary non-polyposis colorectal cancer (HNPCC). HNPCC families registered at five London Genetics Centres and a specialised Colorectal family cancer clinic (CFCC) were identified. Ascertainment of management and outcome details were obtained by scrutiny of patient records and by correspondence with General practitioners (GPs). Two hundred and three families with HNPCC were identified. 79.5% (403/507) of at-risk relatives ascertained were contacted by the genetics centres, and 80.2% (65/81) by the CFCC (P = 1.0). 54.8% (211/385) of probands and relatives within genetics centres’ catchment areas were advised to undertake a surveillance programme, compared with 82.1% (64/78) of those cared for by the CFCC (P < 4.2 × 10−6). Adherence to surveillance guidelines was 76.6% (49/64) in individuals cared for by the only centre that undertook responsibility for surveillance follow-up (CFCC) and 41.7% (88/211) for the genetics centres, which did not assume responsibility (P < 8.9 × 10−7) (using two sided P-values for P (O ≥ E|O ≤ E)). 15.3% of GPs were unaware their patient had been recommended a surveillance programme, 65% did not know who was responsible for ensuring surveillance follow-up. A questionnaire to fifteen UK genetics centres demonstrated that the majority (86.7%) did not assume responsibility for surveillance follow-up. Since surveillance adherence is clearly better where centres assume responsibility for follow-up, it is recommended that regional or national registers of HNPCC families be developed and maintained to ensure effective management.
Similar content being viewed by others
Abbreviations
- CFCC:
-
Colorectal family cancer clinic
- CRC:
-
Colorectal cancer
- EC:
-
Endometrial cancer
- GP:
-
General practitioner
- HNPCC:
-
Hereditary non-polyposis colorectal cancer
- MMR:
-
Mismatch repair
- PPV:
-
Positive predictive value
References
Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM et al (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89(23):1758–1762
Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M et al (2001) The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121(4):830–838
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129(2):415–421
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218
Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71(3):677–685
Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G et al (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19(20):4074–4080
Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH et al (1995) Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 31A(7–8):1145–1148
Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834
Jarvinen HJ, Mecklin JP, Sistonen P (1995) Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108(5):1405–1411
Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI (2003) Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 95(3):230–236
Aktan-Collan K, Mecklin JP, de la Chapelle A, Peltomaki P, Uutela A, Kaariainen H (2000) Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 37(2):108–113
Halbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK et al (2004) Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164(17):1881–1887
Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA et al (2005) Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 128(2):280–287
Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG (2004) Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 1;22(1):39–44
Myers RE, Ross E, Jepson C, Wolf T, Balshem A, Millner L, Leventhal H (1994) Modeling adherence to colorectal cancer screening. Prev Med 23(2):142–151
Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1;89(19):1406–1422
Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT (1999) Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 5;281(17):1618–1622
Levin B, Smith RA, Feldman GE, Colditz GA, Fletcher RH, Nadel M, Rothenberger DA, Schroy PS III, Vernon SW, Wender R (2002) National Colorectal Cancer Roundtable. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer 15;95(8):1618–1628. Erratum in: Cancer 2002;15;95(12):2580
Bulow S, Bulow C, Nielsen TF, Karlsen L, Moesgaard F (1995) Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 30(10):989–993
Bussey HJ (1987) The familial polyposis coli register. Ann Acad Med Singapore 16(3):532–534
Dunlop MG (2002) Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 51:V21–V27
Mecklin JP, Jarvinen HJ (2005) Surveillance in Lynch syndrome. Fam Cancer 4(3):267–271
Acknowledgements
Our thanks go to all staff at the CR-UK Family Cancer Clinic, the Cancer Genetics Clinic, Royal Marsden NHS Foundation Trust, the North East Thames Regional Genetics Centre, the North West Thames Regional Genetics Service, the South East Thames Regional Genetics Centre and the South West Thames Regional Genetics Service for providing access to data to make this work possible. Our thanks also go to Fiona Lewis for her attention to detail during the manuscript revisions. We are grateful to the NHS: Audit, Information & Analysis Unit for funding the audit on which this paper is based.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Geary, J., Thomas, H.J.W., Mackay, J. et al. The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC). Familial Cancer 6, 13–19 (2007). https://doi.org/10.1007/s10689-006-9000-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-006-9000-4